Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2012
03/01/2012US20120053073 Methods for Detecting Signatures of Disease or Conditions in Bodily Fluids
03/01/2012US20120053071 Method for the detection of dna methylation patterns
03/01/2012US20120053069 Determination of a Genotype of an Amplification Product at Multiple Allelic Sites
03/01/2012US20120053068 Real-time pcr of targets on a micro-array
03/01/2012US20120053066 Methods for predicting esophageal adenocarcinoma (eac)
03/01/2012US20120052528 Method for producing selective medium and use thereof
03/01/2012US20120052527 Laboratory method and experimental specimen for validating the efficacy of antimicrobial agents on bovine carcasses
03/01/2012US20120052526 Tissue Infiltration Method
03/01/2012US20120052525 Polymers for growing cells
03/01/2012US20120052524 Cell evaluation system using cell sheet and method for using the system
03/01/2012US20120052523 Devices and methods for observing the cell division
03/01/2012US20120052522 Apparatus And Method For The Study Of Metabolism
03/01/2012US20120052521 Sheath flow device and method
03/01/2012US20120052520 Methods, compositions and a kit suitable for determining the concentration of gamma-hydroxy butyric acid (ghb) in a sample
03/01/2012US20120052519 Methods for assaying alpha-l-iduronidase enzymatic activity
03/01/2012US20120052518 Fluorescent probe for measuring protease
03/01/2012US20120052517 Methods for testing an immune response using cultures of t cells, b cells and dendritic cells
03/01/2012US20120052515 Therapeutic applications of noncovalent dimerizing antibodies
03/01/2012US20120052510 Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
03/01/2012US20120052509 Method for measuring in vivo hematotoxicity with an emphasis on radiation exposure assessment
03/01/2012US20120052508 Genetic markers and diagnostic methods for resistance of breast cancer to hormonal therapies
03/01/2012US20120052507 Phospholinked dye analogs with an amino acid linker
03/01/2012US20120052506 Cyanine dyes
03/01/2012US20120052505 Methods for detecting embryonic stem cells, induced pluripotent stem cells, or cells undergoing reprogramming to produce induced pluripotent stem cells
03/01/2012US20120052504 Methods of screening for risk of proliferative disease and methods for the treatment of proliferative disease
03/01/2012US20120052503 Kit for detecting neisseria gonorrhoeae strains and method for detecting neisseria gonorrhoeae strains using the same
03/01/2012US20120052502 Real-time pcr detection using stabilized probes
03/01/2012US20120052501 Kit for detecting htlv strains and use thereof
03/01/2012US20120052500 Kit for detecting chlamydia trachomatis strains and method for detecting chlamydia trachomatis strains using the same
03/01/2012US20120052499 Methods For Whole-Cell Analysis Of Gram-Positive Bacteria
03/01/2012US20120052498 Detection of Nucleic Acids
03/01/2012US20120052497 Method of simultaneously amplifying target sequences from salmonella spp. and e. coli o157:h7 and kit therefor
03/01/2012US20120052496 Compositions, kits and methods for detection of campylobacter nucleic acid
03/01/2012US20120052495 Oligonucleotides for detecting listeria monocytogenes and use thereof
03/01/2012US20120052494 OLIGONUCLEOTIDES FOR DETECTING E. coli O157:H7 STRAINS AND USE THEREOF
03/01/2012US20120052493 Oligonucleotides for detecting listeria spp. and use thereof
03/01/2012US20120052492 Oligonucleotides for detecting listeria spp. and use thereof
03/01/2012US20120052491 Cell analyzer and cell analyzation method
03/01/2012US20120052490 Methods and systems for monitoring reactions
03/01/2012US20120052489 Methods and compositions for sequencing nucleic acids using charge
03/01/2012US20120052488 Photodamage mitigation compounds and systems
03/01/2012US20120052487 Methods and compositions for selecting sirna of improved functionality
03/01/2012US20120052486 Identification of high grade or >= cin2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (hpv) and hpv-associated cancers
03/01/2012US20120052485 Sperm separation system
03/01/2012US20120052484 Methods of diagnosing cervical cancer
03/01/2012US20120052483 Kit for detecting hiv-1 and method for detecting hiv-1 using the same
03/01/2012US20120052482 Kit for detecting hepatitis c virus and method of detecting hepatitis c virus using the same
03/01/2012US20120052481 Assays for detecting modified compounds
03/01/2012US20120052091 Potomac horse fever isolates
03/01/2012US20120052079 Compositions, Kits, and Methods for Predicting Anti-Cancer Response to Anthracyclines
03/01/2012US20120052071 Tumor markers and methods of use thereof
03/01/2012US20120052066 Markers and methods for assessing and treating lupus patients susceptible to photoprovocation
03/01/2012US20120052059 Regulatory b cells and their use
03/01/2012US20120052057 method for selecting responders to blockade of integrin receptors
03/01/2012US20120052051 Method of treating diabetes - related vascular complications
03/01/2012US20120052048 Antibacterial phage, phage peptides and methods of use thereof
03/01/2012US20120052006 Gold/lanthanide nanoparticle conjugates and uses thereof
03/01/2012DE102010048899B3 Verfahren zum Diagnostizieren aneuploider kolorektaler Tumore A method for diagnosing aneuploid colorectal tumors
03/01/2012DE102010038330A1 Verfahren, Vorrichtung und Testkit für Molekularbiologische Reaktionen Method, device and test kit for molecular biological reactions
03/01/2012CA2847151A1 Cell characterisation
03/01/2012CA2809498A1 Methods for enriching pluripotent stem cell-derived cardiomyocyte progenitor cells and cardiomyocyte cells based on sirpa expression
03/01/2012CA2809342A1 Means and methods for the detection of a predisposition of a female subject to recurrent pregnancy loss (rpl), preeclampsia (pe) and/or fetal growth restriction (fgr)
03/01/2012CA2809308A1 Assays for detecting modified compounds
03/01/2012CA2809085A1 Enzymatic reagent inks for use in test strips having a predetermined calibration code
03/01/2012CA2809055A1 Defining diagnostic and therapeutic targets of conserved free floating fetal dna in maternal circulating blood
03/01/2012CA2808539A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases
03/01/2012CA2808227A1 Antimicrobial method for fermentation processes
03/01/2012CA2807823A1 Methods for predicting anti-cancer response
03/01/2012CA2807505A1 Association of rare recurrent genetic variations to attention-deficit, hyperactivity disorder (adhd) and methods of use thereof for the diagnosis and treatment of the same
03/01/2012CA2807244A1 A novel diagnostic and therapeutic target in inflammatory and/or cardiovascular diseases
03/01/2012CA2803693A1 Methods for nucleic acid capture and sequencing
02/2012
02/29/2012EP2423335A2 Chimeric immunomodulatory compounds and methods of using the same
02/29/2012EP2423334A2 Non-invasive fetal genetic screening by digital analysis
02/29/2012EP2423333A1 Prognostic markers and therapeutic targets for lung cancer
02/29/2012EP2423332A1 Prognostic markers and therapeutic targets for lung cancer
02/29/2012EP2423331A2 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
02/29/2012EP2423330A1 Method of prognosing recurrence of prostate cancer
02/29/2012EP2423329A1 Method of prognosing recurrence of prostate cancer
02/29/2012EP2423327A2 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
02/29/2012EP2423326A2 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
02/29/2012EP2423325A1 Method of preparing libraries of template polynucleotides
02/29/2012EP2423324A1 Probe set for identification of nucleotide mutation, and method for identification of nucleotide mutation
02/29/2012EP2423323A1 Method for evaluating cancer
02/29/2012EP2423322A1 Hybridization probes for nucleic acid detection, universal stems, methods and kits
02/29/2012EP2423321A2 Use of HE4 and other biochemical markers for assessment of endometrial and uterine cancers
02/29/2012EP2423310A1 Cancer antigen helper peptide
02/29/2012EP2423302A1 New serum-free medium for inducing pluripotent stem cells quickly with high efficiency and method using thereof
02/29/2012EP2423216A1 Replication competent hepatitis C virus and methods of use
02/29/2012EP2421994A2 Bin1 as a prognostic marker in cardiovascular disease
02/29/2012EP2421993A1 Biological specimen collection/transport compositions and methods
02/29/2012EP2421992A1 Hp1alpha as a prognostic marker in human cancer
02/29/2012EP2421991A1 Breast cancer susceptibility gene gt198 and uses thereof
02/29/2012EP2421990A1 Compositions for use in security marking
02/29/2012EP2421989A1 Cellular assay employing detectable protein
02/29/2012EP2421988A2 Method of diagnosing bladder cancer
02/29/2012EP2421987A1 Use of methylation status of mint loci as a marker for rectal cancer
02/29/2012EP2421969A2 Selective detection of bordetella species
02/29/2012EP2421955A1 Methods for obtaining fetal genetic material
02/29/2012EP2421883A1 Trapping compounds and method for identifying reactive metabolites
02/29/2012EP2421881A1 Engineered demeter 5-methylcytosine dna glycosylase with improved yield, stability and solubility